• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAtreca
    Picture of Atreca logo

    BCEL — Atreca News Story

    $0.090.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      $4.06m
    • Enterprise Value
      -$17.32m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BCEL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BCEL Dividends
    All News

    NASDAQ RESUMED AT 03:19 PM

    Picture of Atreca logoAtreca
    24/01/2020 20:19
    NASDAQ RESUMED  BCEL.O  AT 03:19 PM
    

    Recent news on Atreca

    See all news
    • Brief: Baker Bros Advisors Reports 19.99% Passive Stake In Atreca As Of Dec 31, 2023 - SEC Filing

      10/01/2024 22:12
    • Brief: Immunome To Acquire Antibody-Related Assets And Materials From Atreca

      26/12/2023 13:59
    • Brief: Atreca Says On Dec 19 Asset Sale And Other Transactions Contemplated By Agreement, Board Approved Liquidation And Dissolution Of Co

      26/12/2023 13:52
    • Brief: Atreca Q3 basic EPS USD -0.92

      14/11/2023 21:31
    • Brief: Atreca Announces Agreement To Terminate Lease And Departure Of CFO Herb Cross

      21/09/2023 13:22

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.